ODC1 and papilloma: Its topical application strongly inhibits inflammation caused by 12-O-tetradecanoylphorbol-13-acetate (TPA), cell proliferative hyperplasia, ornithine decarboxylase (ODC) activity, production of ROS, DNA oxidative changes, and papilloma formation (111-113).